Helping an older adult stay consistent with breathing treatments can feel like a full-time job - especially when COPD, asthma ...
Liquidia Technologies ($LQDA) announced an update on their ongoing clinical study. Liquidia Technologies (LQDA) has announced plans for a Phase 3 ...
As of Monday, December 15, Quipt Home Medical Corp.’s QIPT share price has surged by 34.67%, which has investors questioning ...
The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...
6don MSN
Using both genetic information and AI to diagnose pneumonia could curb the overuse of antibiotics
Lung infections like pneumonia are among the world's top killers—but diagnosing them is notoriously hard. Now, researchers at ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with Fujifilm as the ...
In-hospital mortality by day 28 did not significantly differ based on use of ketamine or etomidate to induce anesthesia in ...
A bet said Snowball would kill Herbie, but the animals' quiet rebellion taught columnist Caroline Gainer a lesson about ...
The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...
Use of inhaled corticosteroids by pregnant mothers with asthma may protect infants against reduced lung function at 4 to 6 weeks of age.
The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...
Savara Inc. (the "Company"), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will present and host one on one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback